Chronic semaglutide ↗ made obese mice lose weight without dulling a single one of their five tastes. The taste machinery was intact down to the cells and the genes. The drug changed how much the animals ate. It did not change what they could taste.
That finding, published online June 27 in Molecular Metabolism ↗, lands on a question that has followed the GLP-1 weight-loss drugs into the clinic. Some people on semaglutide, the molecule sold as Ozempic and Wegovy, report that food tastes different. Two days ago we covered a human pharmacovigilance signal tying GLP-1 drugs to smell and taste complaints ↗, with the smell side larger than the taste side. That human signal spanned the class. It named both semaglutide and tirzepatide ↗, the dual GLP-1 and GIP receptor ↗ drug sold as Mounjaro and Zepbound. The Molecular Metabolism work tested only semaglutide, so it speaks to the class question without closing it. Those reports are real experiences. What they cannot tell you is whether the drug damages the taste system itself or whether something upstream changed and the tongue is a bystander. A self-report cannot separate "I taste less" from "I want less."
What the mice actually showed
The researchers put diet-induced obese mice through a brief-access gustometer, a rig that measures how eagerly an animal licks a tastant in short trials before any calories have a chance to register. The short window is the point. It isolates taste from the gut feedback that normally follows a meal. The mice were tested on sweet, bitter, sour, salty, and fatty tastants.
Chronic semaglutide produced the expected robust weight loss. It did not change lick rates for any of the five tastants. When the team ran a full range of sucrose concentrations and fit the response curves, the treated and untreated mice landed on similar curves with comparable EC50 values. EC50 is the concentration at which the response reaches half its maximum, the standard yardstick for how sensitive a system is to a stimulus. Same EC50 means same sweet sensitivity. The drug did not raise the bar for detecting sugar.
The tissue agreed with the behavior. Semaglutide did not change the abundance of taste receptor cell subtypes in the circumvallate papilla, the large taste-bud-bearing bumps at the back of the tongue, and it did not change expression of the genes that run taste receptor signaling and neurotransmission. The hardware that turns a sugar molecule into a nerve signal was untouched.
One thing did move. The semaglutide mice modestly increased their total licking and their trial initiation for sucrose. They engaged with the sweet solution more, not less. That is the opposite of a blunted palate. It points to a change in behavioral drive rather than in perception.
Why the distinction is the story
If the taste system is intact and the eating still drops, then the appetite effect of these drugs is not running through the tongue. The authors put it plainly: GLP-1 receptor agonists likely influence ingestive behavior through mechanisms independent of taste signaling, probably involving motivation. The wanting changed. The tasting did not.
That reframes the human taste complaints rather than refuting them. People can genuinely experience food as less appealing while their peripheral taste organs work fine, because appeal is built in the brain from far more than receptor output. Expectation, satiety, nausea, and the reward value of eating all feed into what a meal feels like. A controlled animal study measuring the taste apparatus directly is the right tool for the mechanistic question, in a way a human survey cannot be. It is also a mouse study, on one drug, under one set of conditions, and it does not measure smell, which carried the larger share of the human signal.
The molecular reading matters for the rest of the field. Semaglutide hits the GLP-1 receptor ↗, a receptor expressed in the brain circuits that set how rewarding food is, not primarily in the taste buds. A drug that suppressed eating by deadening taste would be a crude tool with a predictable downside. A drug that works on motivation while leaving the senses intact is a different and more precise object, and it sets a cleaner target for the appetite molecules that come after it: change the wanting, leave the tasting alone.